JCIJohnson Controls International plc Insider Trading
Latest: VP & Pres, GP & Solutions Sold $12.5M of Shares · May 2026
2 filings analyzed·Latest 2026-05-18
Insider buys
0
Insider sells
2
Unique insiders
2
Direction
Net selling
May 2026
2026-05-18
low
Grabowski Todd M
Sell
VP and President, Americas
4,274 shares
$621,867
@ $145.50
Significance3/10
VP Americas Todd M Grabowski sold 4,274 JCI shares at $145.50 on 2026-05-14 for $621,867.00
Grabowski sold 4,274 shares at $145.50, reducing his holdings by 13.2% to 28,015 shares. The sale occurred near the stock's 52-week high of $147.32, and the current price of $137.50 is 6.7% below that peak. His prior two sales at JCI both showed positive 90-day returns (3.3% and 2.7%), meaning the stock subsequently rose after those sales—a pattern that does not support well-timed selling at this ticker. The magnitude of this transaction is modest relative to his total holdings, and the sale sits in a relatively elevated price zone for the stock, but the historical data at JCI does not indicate he has successfully timed exits before.
VP of GP & Solutions Schlitz Lei Zhang exercises stock options and sells net 26k shares; prior sales have shown conflicting timing outcomes.
Schlitz Lei Zhang, VP and President of GP & Solutions, executed a paired exercise-and-sell transaction, acquiring roughly 63k shares through two option exercises and immediately disposing of approximately 89k shares, resulting in a net reduction of over 26k shares. The current sale prices cluster tightly in the $140–$142 range, with the stock currently trading just below its 52-week high and near the levels where Zhang is transacting. Zhang has now completed four open-market sales in the past six months, with no open-market purchases in the same window—a consistent pattern of net disposition. However, his prior sales at this ticker tell a mixed timing story: the most recent prior sale in late November was well-timed, as the stock subsequently declined in the following month, yet that same sale was poorly timed over a longer horizon as the stock rebounded significantly. An earlier November sale followed the opposite pattern—an initial decline that reversed into substantial gains. This conflicting near-term versus longer-term timing, combined with the profitable fundamentals and lofty valuation multiple the company carries, means this sale warrants attention without signaling clear insider alarm.
Add JCI to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.